Back
Vertex Pharmaceuticals Incorpor (VRTX)
BiotechnologyVRTX · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$548.03
+1.46%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$15.32
ROE
24.2%
Gross margin
54.4%
Debt/Equity
0.10x
Revenue growth
7.8%
Vertex Pharmaceuticals Incorpor — company intelligence
Earnings surprises
Q2 2026$4.73 vs $4.82 est-2.0%
Q1 2026$4.47 vs $4.40 est+1.7%
Q4 2025$5.03 vs $5.17 est-2.8%
Q3 2025$4.80 vs $4.65 est+3.1%
Analyst consensus · 37 analysts
30 Buy6 Hold1 Sell
Updated Aug 19, 2026
Insider activity · 90 days
4 buys7 sellsnet +7,198 shares
Tatsis OuraniaBuy 8,251 · Jul 21, 2026
Sachdev AmitBuy 8,251 · Jul 21, 2026
Garber Alan MBuy 32 · Jul 15, 2026
Recent SEC filings
10-Q — Quarterly reportAug 4, 2026
8-K — Material event reportAug 3, 2026
4 — Insider transaction reportJul 23, 2026
Latest news
Uber, ServiceNow And A Health Care Stock On CNBC’s ‘Final Trades’ — Benzinga · 4d ago
Vertex Pharmaceuticals' Rally Has a New Engine -- and Wall Street Thinks the Best Is Still Ahead — Yahoo · 5d ago
Are Wall Street Analysts Bullish on Vertex Stock? — Yahoo · 5d ago
Vortex Energy Announces Final Ambient Noise Tomography Results for the Robinsons River Salt Project — Yahoo · 1w ago
3 Cash-Producing Stocks on Our Watchlist — Yahoo · 1w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.